| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $39.2M | $18.7M | $20.0M |
| YoY Revenue Growth % | +110.3% | -6.8% | — |
| Gross Profit | $24.0M | -$2.9M | — |
| Gross Margin % | 61.1% | -15.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$28.5M | -$65.3M | -$30.6M |
| Operating Margin % | -72.7% | -80.0% | -80.0% |
| Net Income (GAAP) | -$41.4M | -$73.9M | -$33.8M |
| EBITDA (Normalized) | -$28.1M | -$65.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$14.8M | -$25.1M | -$14.9M |
| Capital Expenditures (CapEx) | $485.3K | $332.4K | — |
| Free Cash Flow (FCF) | -$15.3M | -$25.4M | -$14.9M |
| FCF Margin % | -38.9% | -80.0% | -74.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $7.8M | $5.1M | — |
| Total Debt (Short + Long Term) | $82.1M | $70.1M | — |
| Total Stockholders' Equity | -$67.1M | -$61.4M | — |